The repurchase is part of a $3 billion share repurchase program announced in December 2017. The plan will be funded through a combination of debt financing and parent cash.
The final settlement for the accelerated stock repurchase is expected to occur in the first quarter of 2019. The number of shares will be based on the daily volume-weighted average share price of Humana common stock over the course of the agreement with Goldman Sachs.
More articles on healthcare finance:
UnitedHealth Group to buy Seattle primary care clinic
CMS ‘closely’ watching decline in Medicaid enrollment from Arkansas’ work requirements
Northwell Health, Memorial Sloan Kettering, Westmed join Oscar’s network
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
